Remote Health Monitoring is Transforming Physician-Pharmacist Teamwork

Pharmacists are seizing new roles in remote care


From office visits to continuous connection

Remote health monitoring, often referred to as remote physiologic monitoring (RPM), is rapidly evolving from a temporary trend into a foundational pillar of modern primary care. As this transformation unfolds, one thing is becoming increasingly clear: effective collaboration between pharmacists and physicians is no longer optional, it’s essential.

Recent research underscores this shift and highlights how healthcare professionals, particularly pharmacists, can leverage continuous data to deliver more proactive, predictive, and personalized care.

What the Latest Evidence Reveals

A national analysis of Medicare data encompassing 754 primary care practices from 2019 to 2021 found that practices adopting RPM experienced a 20 percent increase in Medicare revenue over two years compared to those that did not. While most of the increase stemmed from RPM billing itself, roughly a quarter resulted from additional office visits and enhanced health management activities.

Crucially, these practices did not reduce access for non RPM patients. In fact, they managed higher overall patient volumes, including more high risk and underserved populations, a sign that RPM may expand, rather than restrict, access to care.

However, researchers cautioned that if RPM scales without thoughtful design, total healthcare spending could rise. Sustainable reimbursement models and data driven workflows will be key to ensuring value creation rather than volume inflation.

Why This Matters for Pharmacists and Physicians

As physicians increasingly integrate remote monitoring into their practices, three major opportunities emerge for interprofessional collaboration:

  1. Earlier intervention and real time medication management
    Continuous physiologic data, such as blood pressure, body weight in heart failure, or glucose fluctuations, enable clinicians to spot problems before they escalate. When pharmacists are integrated into the care team, they can review medications, adjust regimens, and coordinate with physicians in real time, serving as “medication detectives” who close the gap between monitoring and action.
  2. Targeted focus on high risk, high complexity patients
    RPM programs tend to attract patients with multiple comorbidities and complex medication regimens. Pharmacists bring critical value here by optimizing therapy, preventing medication errors, reducing hospitalizations, and demonstrating measurable cost and adherence benefits.
  3. Expanding practice capacity and streamlining workflow
    Contrary to early skepticism, RPM has been shown to help practices see more patients without compromising care quality. When pharmacists are embedded within RPM workflows, they can triage medication related alerts, allowing physicians to focus on higher acuity tasks. Clear protocols for who responds to which alerts can transform team efficiency.

Keys to Successful Implementation

For practices developing pharmacist led RPM services, several factors are critical:

  • Device selection and integration: Choose clinically relevant devices that integrate seamlessly with the EMR or care management platform.
  • Patient selection: Establish clear eligibility criteria, acknowledging that not all patients have the technology or health literacy required.
  • Billing and documentation: Implement structured processes to ensure revenue capture for both monitoring and pharmacist interventions.
  • Role clarity: Define responsibilities for pharmacists and physicians when triaging or responding to alerts.
  • Outcome tracking: Measure and communicate results such as reduced visits, improved adherence, lower costs, and enhanced satisfaction.
  • Equity considerations: Ensure that underserved and technologically limited populations are included, not excluded, from RPM participation.

Bringing This to Life: A Practical Pilot

A scalable way to begin is through a small, high risk patient pilot; for example, enrolling individuals with heart failure and multiple medications. Pharmacists can follow defined protocols (e.g., “if BP > 140/90 on two occasions, pharmacist reviews and acts”) and track interventions through a shared dashboard.

Patient education plays an essential role: explaining that a clinical pharmacist is actively monitoring therapy can improve engagement and adherence. Reporting outcomes such as reduced hospitalizations, fewer therapy changes, or higher satisfaction, helps demonstrate the tangible impact of pharmacist integration within the care team.

The Bottom Line

Remote health monitoring is no longer a futuristic concept, it’s a cornerstone of proactive, data driven healthcare. For physicians and pharmacists alike, it represents a new era of teamwork: one where medication management, real-time data, and preventive care intersect to produce better outcomes.

By embedding pharmacists within RPM workflows, healthcare systems can transform reactive treatment into predictive, coordinated care, closing the loop between technology, therapy, and trust.


Drugs.com. (2025, November 6). Remote health monitoring increases doctors’ ability to see more patients. Drugs.com. https://www.drugs.com/news/remote-health-monitoring-increases-doctors-ability-see-more-patients-127419.html

Medical Xpress. (2025, November 5). Remote patient monitoring boosts primary care revenue and access. Medical Xpress. https://medicalxpress.com/news/2025-11-remote-patient-boost-primary-revenue.html

Medical Economics. (2025, November 5). Remote monitoring boosts Medicare revenue by 20% for primary care practices, study finds. Medical Economics. https://www.medicaleconomics.com/view/remote-monitoring-boosts-medicare-revenue-by-20-for-primary-care-practices-study-finds

ICT Health. (2025, November 6). Remote monitoring boosts primary care efficiency and access. ICT Health. https://www.icthealth.org/news/remote-monitoring-boosts-primary-care-efficiency-and-access

Stern, A. D., et al. (2025). Remote patient monitoring and primary care practice performance: A national cohort analysis. [Study referenced in Drugs.com and Medical Economics coverage]. Harvard Business School/Health Care Delivery Science Center.

Previous Article

Why Chasing Billing Codes Keeps Pharmacy Small, And How Measurable Impact Rewrites The Rules

Next Article

Pharmacy Unbounded: Why The Future Isn’t Behind The Counter